SEC Filing Summary: AspenBio Pharma, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by AspenBio Pharma, Inc. on June 7, 2010. The registrant is incorporated in Colorado and is based in Castle Rock, Colorado. The filing reports on a specific corporate event rather than a standard financial reporting period.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on regulatory updates rather than financial performance data.
Material Changes and Events
- Item 8.01 (Other Events): The Company issued a press release on June 7, 2010, titled "AspenBio Pharma Updates on AppyScore™ FDA 510(k) Filing and Data Analysis."
- The press release is included as Exhibit 99.1 to this filing.
Guidance, Outlook, and Risks
The filing does not contain specific financial guidance, management commentary on future outlook, or detailed risk factors within the main text. The primary focus is the update regarding the FDA 510(k) filing status for the AppyScore™ product. Investors should refer to the attached press release (Exhibit 99.1) for specific details on the data analysis and regulatory status.
Key Facts for Investor Verification
- Verify the specific status and content of the AppyScore™ FDA 510(k) filing by reviewing Exhibit 99.1.
- Confirm the impact of the FDA filing update on the Company's product pipeline and commercialization timeline.
- Note that this filing does not contain updated financial statements or earnings data.